ArticleOncology research2023

Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2.

Yusen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.